{"id":319,"date":"2020-06-02T13:49:10","date_gmt":"2020-06-02T04:49:10","guid":{"rendered":"https:\/\/gucvmed.med.gunma-u.ac.jp\/0_web\/?page_id=319"},"modified":"2020-06-02T13:49:10","modified_gmt":"2020-06-02T04:49:10","slug":"2018%e5%b9%b4%e6%a5%ad%e7%b8%be","status":"publish","type":"page","link":"https:\/\/gucvmed.med.gunma-u.ac.jp\/?page_id=319","title":{"rendered":"2018\u5e74\u696d\u7e3e"},"content":{"rendered":"
\n

2018\u5e74\u696d\u7e3e\u30fb\u6b27\u6587<\/h4>\n

Aihara K,Kato Y,Suzuki S,Arita T,Yagi N,Semba H,Kano H,Matsuno S,Otsuka T,Uejima T,Oikawa Y,Kunihara T,Yajima J,Yamashita T<\/strong>
\nPrognostic value of the heart rate profile during exercise in patients with atrial fibrillation.
\nEur J Prev Cardiol. 2018 Oct;25(15):1634-1641.<\/p>\n

Aizawa Y, Hosaka Y, Oda H, Fuse K, Okabe M, Kaneko Y, Takahashi N, Zaizen H, Aizawa Y, Fukuda K:<\/strong>
\nDynamicity of Hypothermia-Induced J Waves and the Mechanism.
\nHeart Rhythm, in press.<\/p>\n

Akuzawa N, Kurabayashi M. Native valve endocarditis due to Escherichia coli infection: a case report and review of the literature. <\/strong>
\nBMC Cardiovasc Disord. 2018 Oct 19;18(1):195.<\/p>\n

Akuzawa N, Kurabayashi M. Multiple spontaneous hemorrhages after commencing warfarin therapy. <\/strong>
\nSAGE Open Med Case Rep. 2018 May 21;6:2050313X18778380.<\/p>\n

Dharmawan T, Nakajima T, Ohno S, Iizuka T, Tamura S, Kaneko Y, Horie M,
\nKurabayashi M.<\/strong>
\nIdentification of a novel exon3 deletion of RYR2 in a family with
\ncatecholaminergic polymorphic ventricular tachycardia.
\nAnn Noninvasive\u3000Electrocardiol. 2019;e12623<\/p>\n

Iso T,Haruyama H,Sunaga H,Matsui H,Matsui M,Tanaka R,Umbawaran Y,Syamsunaruno MRAA,Putri M,Yamaguchi A,Hanaoka H,Negishi K,Yokoyama T,Kurabayashi M.<\/strong>
\nCD36 is indispensable for nutrient homeostasis and endurance exercise capacity during prolonged fasting.
\nPhysiol Rep 2018,Sep;6(9):e13884<\/p>\n

Ishiura H, Doi K, Mitsui J, Yoshimura J, Matsukawa MK, Fujiyama A, Toyoshima Y, Kakita A, Takahashi H, Suzuki Y, Sugano S, Qu W, Ichikawa K, Yurino H, Higasa K, Shibata S, Mitsue A, Tanaka M, Ichikawa Y, Takahashi Y, Date H, Matsukawa T, Kanda J, Nakamoto FK, Higashihara M, Abe K, Koike R, Sasagawa M, Kuroha Y, Hasegawa N, Kanesawa N, Kondo T, Hitomi T, Tada M, Takano H, Saito Y, Sanpei K, Onodera O, Nishizawa M, Nakamura M, Yasuda T, Sakiyama Y, Otsuka M, Ueki A, Kaida KI, Shimizu J, Hanajima R, Hayashi T, Terao Y, Inomata-Terada S, Hamada M, Shirota Y, Kubota A, Ugawa Y, Koh K, Takiyama Y, Ohsawa-Yoshida N, Ishiura S, Yamasaki R, Tamaoka A, Akiyama H, Otsuki T, Sano A, Ikeda A, Goto J, Morishita S, Tsuji S<\/strong>
\nExpansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy.
\nNat Genet. 2018 Apr;50(4):581-590<\/p>\n

Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators. Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy<\/strong>
\nReport of a Randomized Study. Diabetes Care. 2018 Jun;41(6):1275-1284. <\/p>\n

Kaneko Y, Nakajima T, Iizuka T, Tamura S, Kurabayashi M. <\/strong>
\nA case of atypical fast-slow atrioventricular nodal reentrant tachycardia utilizing a slow pathway extending to the superoanterior right atrium.
\nInt Heart J, in press.<\/p>\n

Kasama S, Toyama T, Suzuki S, Ito Y, Matsumoto N, Kurabayashi M, Kasahara, M<\/strong>
\nAssessment of therapeutic effects of statin on cardiac sympathetic nerve activity and cardiac events in patients with ischemic cardiomyopathy and mild to moderate heart failure
\nNucl Med Commun. In Press<\/p>\n

Kawano T, Shimamura M, Nakagami H, Iso T, Koriyama H, Takeda S, Baba K, Sasaki T, Sakaguchi M, Morishita R, Mochizuki H. <\/strong>
\nTherapeutic Vaccine Against S100A9 (S100 Calcium-Binding Protein A9) Inhibits Thrombosis Without Increasing the Risk of Bleeding in Ischemic Stroke in Mice.
\nHypertension. 2018 Dec;72(6):1355-1364. doi: 10.1161\/HYPERTENSIONAHA.118.11316. PubMed PMID: 30571223.<\/p>\n

Koitabashi N.,Yamaguchi T.,Fukui D.,Nakano T,Umeyama A,Toda K,FUnada R,Ishikawa M,Kawamura R,Okada K,Hatamochi A,Kosho T,Kurabayashi M.<\/strong>
\nPeripartum Iliac Arterial Aneurysm and Rupture in a Patient with Vascular Ehlers-Danlos Syndorome Diagnosed by Next-Generation Sequencing.
\nInt Heart J 2018 Sep 26;59(5):1180-1185<\/p>\n

Murata M,Adachi H,Oshima S,Kurabayashi M.<\/strong>
\nAsympromatic Reactive Hypoglycemia and Inflammatory Reaction in Patients with Coronary Artery Disease
\nInt Heart J 2018 jul 31;59(4):705-712<\/p>\n

Murata M, Adachi H, Nakade T, Oshima S.Glucagon secretion determined by the RIA method is lower in patients with low left ventricular ejection fraction<\/strong>
\nThe new glass study. Diabetes Res Clin Pract. 2018 Oct;144:260-269.<\/p>\n

Nakajima T,Sugawara T,Kaneko Y,Kurabayashi M<\/strong>
\nAtrioventricular Block-induced Torsades de Pointes Associated with KCNA1-G269S.
\nIntern Med 2018 Mar 15;57(6):905-906<\/p>\n

Nakahara T,Toyama T,Kurabayashi M<\/strong>
\nQuantitative Analysis of Iodine Image of Dual-energy Computed Tomography at Rest:Comparison With 99mTc-Tetrofosmin Stress-rest Single-photon Emission Computed Tomography Myocardial Perfusion Imaging as the Reference Standard.
\nJ Thorac Imaging 2018 Mar;33(2):97-104<\/p>\n

Nguyen-Thu H,Ohyama Y,Taketomi-Takahashi A,Nguyen-Cong T,Sugimoto A,Sato M,Sumiyoshi H,Nakamura T,Kurabayashi M,Tsushima Y.<\/strong>
\nAssociation of Aortic Arch Width Assessed by Noncontrast Cardiac Computed Tomography With Cardiac Remodeling,Cardiac Function,and Atherosclerosis in a Japanese Cohort.
\nJ-Thorac Imaging 2018;33(4):240-245<\/p>\n

NIijima K, Obokata M, Kurabayashi, M.<\/strong>
\nPrevalence of and Risk Factors for Paroxysmal Atrial Fibrillation in Patients with Cardiovascular Disease but without diagnosed Atrial Fibrillation.
\nJournal of Medical Research 2018\uff1b\uff14\uff08\uff15\uff09207-212<\/p>\n

Obokata M,Kurosawa K,Ishida H,Ito k,Ogawa T,Ando Y,Kurabayashi M,Negishi K.<\/strong>
\nEchocardiography-based pressure-bolume loop assessment in the evaluation for the effects of indoxylsulfate on cardiovascular function.
\nJ Echocardiogr 2018 Jul 7<\/p>\n

Obokata M,Iso T,Ohyama Y,Sunaga H,Kawaguchi T,Matsui H,Iizuka T,Fukuda N,Takamatsu H,Koitabashi N,Funada R,Takama N,Kasama S,Kaneko Y,Yokoyama T,Murakami M,Kurabayashi M.<\/strong>
\nEarly increase in serum fatty acid binding protein 4 levels in patients with acute myocardial infarction.
\nEur Heart J Acute Cardiovasc Care 2018 Sep;7(6):561-569<\/p>\n

Obokata M,Yogesh NV R,Vojtech M,Sorin P,Barry A B<\/strong>
\nDeterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction
\nEur Heart J 2018 Dec0,1-11 doi:10.1093\/eurheartj\/ehy809<\/p>\n

Obokata M,Thomas P P,Yogesh N V R,Vojtech M,Garvan C K,Barry A B.<\/strong>
\nHaemodynamics,dyspnea,and pulmonary reserve in heart failure with preserved ejection fraction
\nEur Heart J 2018\uff1b39(30)\uff1a2810-2821<\/p>\n

Obokata M,Yogesh N.V.R,Jeong H Y,Brandon M.W,Barry A.B.<\/strong>
\nLeft Atrial Contracture or Failure to Dilate
\nA New Mechanism for Pulmonary Venous Hypertension?
\nHeart Failure 2018:11(9) :e005163<\/p>\n

Obokata M,Yogesh N.V.R,Vojtech ,Garvan C.K,Thomas P.O,Petr J,Barry A.B,<\/strong>
\nMyocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction.
\nJACC 2018:72(1) DOI: 10.1016\/j.jacc.2018.04.039<\/p>\n

Ohyama Y,Alban R,Nadjia K,Bharath A V,Joao A C L<\/strong>
\nImaging Insights on the Aorta in Aging
\nCirculation CVI 2018:11(4),e005617<\/p>\n

Ono Y,Takamatsu H,Inoue M,Mabuchi Y,Ueda T,Suzuki T,Kurabayashi M.<\/strong>
\nClinical effect of long-term administration of tolvaptan in patients with heart failure and chronic kidney.
\nDrug Discov Ther 2018;12(3):154-160<\/p>\n

Sekiguchi M,Muramatsu T,Kashima Y,Okamura A,Tsuchikane E,Mutoh M,Yamane M,Habara M,Oikawa Y,Yoshikawa R.<\/strong>
\nThe Role of the Retrograde Approach in Percutaneous Coronic Total Occlusions:Insights from the Japanese Retrograde Summit Registry
\nInterv.Cardiol.2018,10(4):93-100<\/p>\n

Shimizu Takehisa <\/strong>
\nRelationship between left main coronary artery plaque burden and nonleft main coronary atherosclerosis
\nCoron Artery Dis. 2018 Aug;29(5):397-402<\/p>\n

Suman Shrestha, Hiroaki Sunaga, Hirofumi Hanaoka, Aiko Yamaguchi, Shoji Kuwahara, Yogi Umbarawan, Kiyomi Nakajima, Tetsuo Machida, Masami Murakami, Akihiko Saito, Yoshito Tsushima, Masahiko Kurabayashi, Tatsuya Iso. Circulating FABP4 is eliminated by the kidney via glomerular filtration followed by megalin-mediated reabsorption. <\/strong>
\nSci Rep\u30002018 Nov6;8(1):16451<\/p>\n

Umeyama A, Takama N, Goto K, Kasama S, Kurabayashi M.<\/strong>
\nLow integrated area of desaturation index after adaptive servo-ventilation therapy is a strong indicator to predict fatal cardiovascular events in heart failure patients.
\nTherapeutic Advances in Cardiology\u30002018\uff1b2\uff1a219-26<\/p>\n

Umbarawan Y,Syamsunarno MRAA,Koitabashi N,Obinata H,Yamaguchi A,Hanaoka H,Hishiki T,Hayakawa N,Sano M,Sunaga H,Matsui H,Tsushima Y,Suematsu M,Kurabayashi M,Iso T<\/strong>
\nMyocardial fatty acid uptake through CD36 is indispensable for sufficient bioenergetics metabolism to prevent progression of pressure overload-induced heart failure.
\nSci Rep 2018 Aug 13;8(1):12035<\/p>\n

Umbarawan Y,Syamsunaruno MRAA,Koitabashi N,Yamaguchi A,Hanaoka H,Hishiki T,Nagahata-Naito Y,Obinata H,Sano M,Sunaga H,Matsui H,Tsushima Y,Suematsu M,Kurabayashi M,Iso T<\/strong>
\nGlucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts:evidence from fatty acid-binding protein-4 and -5 knockout mice.
\nCardiovasc Res 2018 jul 1;114(8):1132-1144<\/p>\n

Yamaguchi K,Yamaguchi A,Kashiwagi C,Sawada Y,Taguchi K,Umetsu K,Oshima K,Uchida M,Suzuki M,Kono S,Takemura M,Masubuchi H,Kitahara S,Hara K,Maeno T,Motegi S,Muro Y,Sakairi T,Hisada T,Kurabayashi M.<\/strong>
\nDifferential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
\nRespir Med 2018 jul;140:1-5
\n<\/section>\n

\n

2018\u5e74\u696d\u7e3e\u30fb\u548c\u6587(\u7b46\u982d\u8457\u8005\u4e94\u5341\u97f3\u9806)<\/h4>\n

\u751f\u99d2\u5353\u5b8f\u3001\u9ed2\u6ca2\u5e78\u55e3\u3001\u5ca1\u7530\u9855\u4e5f\u3001\u4e39\u7fbd\u52a0\u5948\u5b50\u3001\u68ee\u7530\u572d\u5b50\u3001\u753a\u7530\u54f2\u7537\u3001\u5009\u6797\u6b63\u5f66\u3001\u6751\u4e0a\u6b63\u5df3<\/strong>
\n\u80ba\u52d5\u8108\u8089\u816b\u306b\u3088\u308a\u53f3\u5fc3\u8ca0\u8377\u3092\u8a8d\u3081\u305f2\u75c7\u4f8b
\n\u8d85\u97f3\u6ce2\u691c\u67fb\u6280\u8853\u30002019,43(suppl):S161<\/p>\n

\u5165\u6c5f\u5fe0\u4fe1\u3001\u98ef\u585a\u8cb4\u58eb\u3001\u7530\u6751\u5cfb\u592a\u90ce\u3001\u4e2d\u5cf6\u3000\u5fe0\u3001\u5009\u6797\u6b63\u5f66\u3001\u91d1\u53e4\u5584\u660e<\/strong>
\n\u5de6\u5ba4\u57fa\u90e8\u4e2d\u9694\u306b\u5bfe\u3059\u308bLow Voltage Area\u306eLAVA Elimination\u304c\u594f\u529f\u3057\u305f\u975e\u865a\u8840\u6027\u5fc3\u7b4b\u75c7\u306b\u5408\u4f75\u3057\u305fVT Storm\u306e1\u4f8b
\nTherapeutic Research\u30002018\u300139\uff08\uff14\uff09\uff1a317-320<\/p>\n

\u7b20\u9593\u3000\u5468<\/strong>
\n\u5fc3\u81d3\u4ea4\u611f\u795e\u7d4c\u6a5f\u80fd\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0
\n\u5fc3\u4e0d\u5168\uff08\u7b2c2\u7248\uff09\u30002018:76(9):602-605<\/p>\n

\u5c0f\u677f\u6a4b\u7d00\u901a<\/strong>
\nTGF\u03b2\u30b7\u30b0\u30ca\u30ea\u30f3\u30b0
\n\u5fc3\u4e0d\u5168\uff08\u7b2c2\u7248\uff09\u30002018\uff1b76\uff089\uff09:301-307<\/p>\n

\u5c0f\u677f\u6a4b\u7d00\u901a<\/strong>
\n\u708e\u75c7\u30de\u30fc\u30ab\u30fc\uff08TNF\u03b1\u3001IL-6,CR\uff50\u3001ST2\uff09
\n\u5fc3\u4e0d\u5168\uff08\u7b2c2\u7248\uff09\u30002018\uff1b76\uff089\uff09:647-653<\/p>\n

\u5c0f\u677f\u6a4b\u7d00\u901a\u3001\u5009\u6797\u6b63\u5f66<\/strong>
\n\u8840\u6db2\u751f\u5316\u5b66\u691c\u67fb(6)\u708e\u75c7\u30de\u30fc\u30ab\u30fc\uff08TNFa\u3001IL-6,CRP,ST2\uff09
\n\u65e5\u672c\u81e8\u5e8a\u30002019,76\uff08\u5897\u520a\u53f79\uff09\uff1a647-653<\/p>\n

\u5c0f\u91dd\u5c2d\u53f8<\/strong>
\nMesalazine\u306b\u3088\u308a\u85ac\u5264\u6027\u597d\u9178\u7403\u6027\u80ba\u708e\u3092\u6765\u305f\u3057\u305f\u3068\u8003\u3048\u3089\u308c\u308b\uff11\u4f8b
\n\u65e5\u5185\u4f1a\u8a8c 107:81-87,2018<\/p>\n

\u9808\u6c38\u6d69\u7ae0\u3001\u677e\u4e95\u5f18\u6a39\u3001\u5c0f\u677f\u6a4b\u7d00\u901a\u3001\u78ef\u3000\u9054\u4e5f\u3001\u6a2a\u5c71\u77e5\u884c\u3001\u5009\u6797\u6b63\u5f66<\/strong>
\n\u6025\u6027\u5fc3\u81d3\u30a4\u30d9\u30f3\u30c8\u306e\u8a3a\u65ad\u3001\u91cd\u75c7\u5ea6\u30de\u30fc\u30ab\u30fc\u3068\u3057\u3066\u306e\u7dda\u7dad\u82bd\u7d30\u80de\u5897\u6b96\u56e0\u5b50FGF21\u306e\u75c5\u614b\u610f\u7fa9
\n\u65e5\u672c\u672a\u75c5\u30b7\u30b9\u30c6\u30e0\u5b66\u4f1a\u96d1\u8a8c\u30002018,(supple)\uff1a123<\/p>\n

\u9ad8\u9593\u5178\u660e<\/strong>
\n\u6a19\u6e96\u30e2\u30cb\u30bf\u30fc\u3067\u306e\u7761\u7720\u547c\u5438\u969c\u5bb3\u8a55\u4fa1\u30b7\u30b9\u30c6\u30e0\u69cb\u7bc9\u3068ASV\u6cbb\u7642\u53cd\u5fdc\u6027\u8b58\u5225\u6307\u6a19\u306e\u540c\u5b9a
\n\u798f\u7530\u8a18\u5ff5\u533b\u7642\u6280\u8853\u632f\u8208\u8ca1\u56e3\u60c5\u5831\u30002018\uff1b30\uff1a65-70<\/p>\n

\u9ad8\u9593\u5178\u660e<\/strong>
\n\u7761\u7720\u6642\u7121\u547c\u5438\u3092\u6709\u3059\u308b\u5fc3\u4e0d\u5168\u75c7\u4f8b\u306b\u304a\u3051\u308b\u5fc3\u4e0d\u5168\u6307\u6a19\u306e\u691c\u8a0e\u3000Editorial comment
\n\u5fc3\u81d3\u30002018;50:624<\/p>\n

\u677e\u4e95\u5f18\u6a39\u3001\u9808\u6c38\u6d69\u7ae0\u3001\u30e8\u30ae \u30a6\u30f3\u30d0\u30e9\u30ef\u30f3\u3001\u5fe0\u6728\u6c99\u8036\u9999\u3001\u78ef\u3000\u9054\u4e5f\u3001\u5c0f\u677f\u6a4b\u7d00\u901a\u3001\u677e\u5742\u3000\u8ce2\u3001\u5cf6\u91ce\u3000\u4ec1\u3001\u5009\u6797\u6b63\u5f66\u3001\u6a2a\u5c71\u77e5\u884c<\/strong>
\n\u8102\u80aa\u9178\u7d44\u6210\u304a\u3088\u3073\u8102\u80aa\u9178\u4f38\u9577\u9175\u7d20Elovl6\u304c\u5fc3\u80a5\u5927\u30fb\u5fc3\u4e0d\u5168\u306e\u75c5\u614b\u306b\u53ca\u307c\u3059\u5f71\u97ff
\n\u65e5\u672c\u672a\u75c5\u30b7\u30b9\u30c6\u30e0\u5b66\u4f1a\u96d1\u8a8c\u30002018,(supple)\uff1a108
\n<\/section>\n","protected":false},"excerpt":{"rendered":"

2018\u5e74\u696d\u7e3e\u30fb\u6b27\u6587 Aihara K,Kato Y,Suzuki S,Arita T,Yagi N,Semba H,Kano H,Matsuno S,Otsuka T,Uejima T,Oikawa Y,Kunihar […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":313,"menu_order":57,"comment_status":"closed","ping_status":"closed","template":"tpl_results.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-319","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/319","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=319"}],"version-history":[{"count":1,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/319\/revisions"}],"predecessor-version":[{"id":320,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/319\/revisions\/320"}],"up":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/313"}],"wp:attachment":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=319"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}